isirv Antiviral Group
News Q1 2022
| Q4 / 2022 | Q3 / 2022 | Q2 / 2022 | Q1 / 2022 | 2021 | 2019 | |||||||||
Q1 2022
New Drug Discovery
Anti-influenza Virus Activity of Methylthio-Formycin Distinct From That of T-705…read more
Clinical Trials & Case Studies
Comparative effectiveness of neuraminidase inhibitors in patients with influenza: A systematic review and network meta-analysis…read more
Reviews
Antivirals Targeting the Neuraminidase…read more
From Acid Activation Mechanisms of Proton Conduction to Design of Inhibitors of the M2 Proton Channel of Influenza A Virus…read more
Antiviral News prepared by: Dr Jeremy C. Jones, Department of Infectious Diseases, St Jude Children’s Research Hospital, Memphis, TN, USA